|
||||||||||||||||||||||||||||||||||||||||||||||||||
Characteristic pattern of human prostatic growth with age* Shu-Jie XIA1, Xiao-Xin XU2, Jian-Bao TENG3 , Chun-Xiao XU3, Xiao-Da TANG1 1Department of Urology, Shanghai 1st People's Hospital, Shanghai 200080, China 2Department of Urology, Linqu People's Hospital, Linqu, Shandong 262600, China 3Department of Urology, Shandong Provincial Hospital, Jinan 250021, China Asian J Androl 2002 Dec; 4: 269-271 Keywords:
|
Age
group |
n |
Prostatic
volume (mL) |
0~ |
105 |
1.410.49 |
10~ |
192 |
6.89
0.70 |
20~ |
210 |
15.29
0.00 |
30~ |
205 |
18.10
0.40 |
40~ |
201 |
20.25
0.40 |
50~ |
176 |
22.30
0.30 |
60~ |
143 |
24.55
0.90 |
70~ |
51 |
27.67
3.00 |
80~92 |
18 |
37.00
4.80 |
Table 2. Prostatic volume in BPH patients above 50 years old (mL). *International prostate symptom score.
Age
group |
n |
IPSS
score* |
Prostatic
volume (mean mL) |
50~ |
122 |
20.6 |
39.4 |
60~ |
88 |
24.6 |
52 |
70~ |
65 |
23.9 |
58 |
80~ |
25 |
27.8 |
74 |
4 Discussion
AM Willams et al [5] indicated that overall prostatic growth rate was 2.36 ?3.52 mL per year and that the growth was increasing with age with the peak of 4.154.98 mL per year at the age of 56~65 years and declined rapidly with the further advancement of age. Based on autopsy data, Berry et al [2] described the normal value of prostate volume, which is 20.06.0 g in subjects aged 21 to 30 years without BPH.
Prostate is an androgen-dependent organ [6-8]. The changes in the production of androgen in different age groups may be the basis of the age difference in prostatic growth rate. McNeal [9] proposed a three-process theory about the genesis and development of BPH: (1) the prophase, with a diffuse growth of the gland, (2) the metaphase, with hyperplasia of the lesser tubercle, (3) the anaphase, with hypertrophy of the node. The unceasing accumulation of the hypertrophic nodes leads to BPH in aging. J T Isaacs et al [10] put forward the following hypotheses in regard to the development of BPH: (1) the dihydrotestosterone (DHT) hypothesis: a shift in prostatic androgen metabolism occurs with aging, leading to an abnormal accumulation of DHT, (2) the embryonic reawakening theory: a change in the prostatic stromal-epithelial interaction occurs in aging, leading to induction of prostatic growth, and (3) the stem cell theory: an increase in the number of prostatic stem cell and/or an increase in the clonal expanding of the stem cells into amplifying and transit cells occur in aging. Sensibarb [11] reported that homeostasis in prostate was maintained by a complex interplay between the opposing actions of cell proliferation and cell death; growth regulatory factors that promote or inhibit cell proliferation and promote cell death have been identified in the prostate and an imbalance between the net cell proliferation and death rates determined by the growth regulatory factors, might result in abnormal growth leading to BPH. However the definitive mechanism of human prostate growth may be the results of interaction of multiple factors [12].
This study revealed the natural course of human prostatic age-stratified growth, the normal prostate volumes in different age groups and the equation of human prostatic growth, thus providing basic data for the researches on prostate and the diagnosis and treatment of BPH. Results suggest that individuals with a prostatic growth rate of 0.50 g ~1.20 g per year fall into it high-risk group of BPH. Our results are in close accordance with those of other authors [2, 3, 13], indicating a similarity of prostatic growth pattern with different populations. The reason for the second rapid growing phase in individuals after 50 years old when their blood testosterone levels begin to drop awaits further investigation.
References
[1] Hiraoaka Y, Akimoto M. Anatomy of the prostate from fetus to adult-origin of benign prostatic hyperplasia. Urol Res 1987; 15: 177.
[2] Berry SJ, Coffey DS, Walsh PC. The development of human benign prostate hyperplasia with age. J Urol 1984; 132: 474.
[3] Gu FL, Shang ZG, Wang TS. The difference of BPH between urban and countryside citizen of Beijing. Chn J Urol 1995; 16: 387.
[4] Xia SJ, Teng JB, Xu XX. Comparison research regarding the volume, the structure of zones and the weight of prostatectomy specimen in prostate. Chn J Urol 1984; 10: 305.
[5] AM Williams, I Simon, PK Landis, W Chistens-Bary, HB Carter, EJ Metter, et al. Prostatic growth rate determined from MRI data: age-related longitudinal changes. J Androl 1999; 20: 474-80.
[6] Xia SJ, Xu CX, Tang XD, Wang WZ, Du DL. Apoptosis and hormonal milieu in ductal system of normal prostate and benign prostate hyperplasia. Asian J Androl 2001; 3: 131-4.
[7] Xia SJ, Tang XD, Ma QZ. Androgen receptor isoforms in human prostatic cancer tissue and LNCap cell line. Asian J Androl 2001; 3: 223-5.
[8] Xia SJ, Hao GY, Tang XD. Androgen receptor isoforms in human and rat prostate. Asian J Androl 2000; 2: 307-10.
[9] McNeal J E. Origin and evolution of benign prostatic enlargement. Invest Urol 1978; 15: 340.
[10] J T Isaacs, Coffey D S. Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 1989; 2: 33-50.
[11] J A Sensibar. Analysis of cell death and proliferation in embryonic stages, normal adult, and aging prostates in human and animals. Microsc Res Tech 1995; 30: 342-50.
[12] Lee C, Koziowski J M, Grayhack J T. Etiology of benign prostatic hyperplasia. Urol Clin of North Am 1995; 22: 237.
[13] Jakobsen H, Torp-Pedersen S, Juul N. Ultrasonic evaluation of age-related human prostate growth and development of benign prostatic hyperplasia. Scand J Urol Nephrol 1988; s107: 26.
Correspondence to: Dr. Shu-Jie XIA, Department of Urology, Shanghai First People's Hospital, 85 Wujin Road, Shanghai 200080, China.
Tel: +86-21-6324 0090 Ext 5712, Fax: +86-21-6324 0825
E-mail: XSJ@citiz.net
* Presented at the First Asia-Pacific Forum on Andrology, 17-21 Oct 2002, Shanghai, China
Received 2002-09-03 Accepted 2002-12-01